General Information |
|
Product |
Apelin Peptide |
Verified Applications |
Immunodepletion, Immunocompetition |
Peptide Description |
Synthetic peptide taken within amino acid region 25-77 on human Apelin protein. |
Accession # |
NCBI: NP_059109 |
|
|
Quantity |
250 µg |
Volume |
100 µl |
Form |
Antigenic Blocking Peptide |
Storage |
-20⁰C for long term storage |
|
|
Competition/Depletion assay |
|
|
|
Uniprot # |
|
Overview |
Endogenous ligand for APJ, an alternative coreceptor with CD4 for HIV-1 infection. Inhibits HIV-1 entry in cells coexpressing CD4 and APJ. Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives. The oral intake in the colostrum and the milk could have a role in the modulation of the immune responses in neonates. May also have a role in the central control of body fluid homeostasis by influencing AVP release and drinking behavior. |
Molecular Function |
G-protein coupled receptor binding, receptor binding |
Subcellular Location |
Secreted |
Expression |
Expressed in the brain with highest levels in the frontal cortex, thalamus, hypothalamus and midbrain. Secreted by the mammary gland into the colostrum and the milk. |
Structure |
Belongs to the apelin family. |
Alternative Nomenclature |
AGTRL1 ligand antibody APEL antibody Apelin-13 antibody APJ endogenous ligand antibody Apln antibody XNPEP2 antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
APEL-101AP | |||
|
APEL-BIOTIN | |||
|
APEL-FITC | |||
|
PC-APEL | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.